Details for Patent: 4,529,593
✉ Email this page to a colleague
Summary for Patent: 4,529,593
Title: | Use of gallium salts to treat disorders of calcium homeostasis |
Abstract: | The present invention comprises a method of preventing or treating a disorder associated with accelerated loss of calcium from bone in a human individual comprising administering to the individual a pharmaceutically acceptable gallium compound. Of especial importance among the disorders which may be thus prevented or treated are hypercalcemia, accelerated bone loss associated with osteopenia, osteoporosis, bone metastasis due to malignant tumors, and hyperparathyroidism. In the method of the present invention gallium compounds may be administered by any and all routes. Although all biocompatible, soluble compounds of gallium may be used in the present invention, gallium nitrate is preferred, most preferably in a pharmaceutically acceptable carrier. |
Inventor(s): | Warrell, Jr.; Raymond P. (New York, NY), Bockman; Richard S. (New York, NY) |
Assignee: | Sloan-Kettering Institute for Cancer Research (New York, NY) |
Application Number: | 06/622,726 |
Patent Claim Types: see list of patent claims | Use; Compound; Composition; Formulation; Delivery; |
Drugs Protected by US Patent 4,529,593
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,529,593
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 1219210 | ⤷ Try a Trial | |||
Germany | 3376387 | ⤷ Try a Trial | |||
European Patent Office | 0109564 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |